MFM Ltd: Roger Waters: We are on the road to Frankfurt
28.3.2023 08:51:33 CEST | news aktuell GmbH | Press release
Concert in Frankfurt to be secured by interim injunction
(London, United Kingdom): Roger Waters has noted with pleasure the decision of the Munich City Council that his 21.05.2023 concert in the Olympiahalle Munich will take place as planned:
"I am very happy to be able to perform in Munich for my fans. A ban on my concert would have been illegal. The City of Munich’s decision is good news for freedom of speech in Germany."
Referring to the concert in Frankfurt on 28.05.2023, for which the City of Frankfurt and the State of Hesse are sticking to the cancellation of the contract, Waters went on to say:
"The decision makers in Frankfurt know that they are on the wrong side of the law and are now completely isolated. They should take an example from their colleagues in Munich and instead of wasting a lot of taxpayers’ money on a futile legal action they should follow Munich’s brave example and support freedom in the arts and free speech in general. The cancel attempts of the Frankfurt politicians are an attack on artistic freedom as a whole. Politicians have no right to intimidate and bully artists and their fans with performance bans."
Waters said that he would continue to fight unceasingly for his right to perform in Frankfurt saying:
”I am fighting for all of our human rights, including the right to freedom of speech. We are on the road to Frankfurt. Frankfurt, here we come!”
If pre-court efforts fail, Waters' lawyers will seek to secure the performance of the concert in Frankfurt on 28.05.2023 through an interim injunction. Commenting on this intention, Waters said:
“Like all the other concerts on my European tour, my concert in Frankfurt will take place. I will enforce this in court if I must. So my fans don’t have to worry."
Contacts
HÖCKER Rechtsanwälte PartGmbB
Rechtsanwalt Prof. Dr. Ralf Höcker
Rechtsanwalt Michael Fengler
E-Mail: contact@hoecker.eu
Tel: +49(0)221-93319-10
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
93% of Europe's Internet Traffic Flows Through Routers – Yet No One Is Paying Attention: Study Demands Action on Digital Sovereignty24.6.2026 10:00:00 CEST | Press release
Berlin, 24 June 2026 – The Sovereignty Alliance for European Network Technology (SAFENet), together with the Innovate Europe Foundation (IE.F) and Berlin-based consultancy iconomy, publishes a new foundational study revealing that 93% of European internet traffic flows through routers and yet the EU has no sovereignty framework for this key component of the digital ecosystem. Meanwhile, Chinese manufacturers already control 37% of the market.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom